In short
Forecast raised- Revenue increased 53.9% year on year to ¥102.0 billion, driven by the consolidation of 森六ReNova and higher production in North America.
- Operating profit increased 210.3% year on year to ¥5.6 billion, and the operating margin improved to 5.5%.
- Reflecting the first-half upside, among other factors, the full-year operating profit forecast was raised from ¥6.5 billion to ¥8.0 billion.
What they reported
this period against the same period a year earlier, and where they now expect the year to endSales
| Period | ¥bn |
|---|---|
| FY25 Q1 | 36.3 |
| FY25 Q2 | 35.4 |
| FY25 Q3 | 36.3 |
| FY25 Q4 | 38.2 |
| FY26 Q1 | 33.8 |
| FY26 Q2 | 32.5 |
| FY26 Q3 | 31.2 |
| FY26 Q4 | 36.4 |
| FY27 Q1 | 48.2 |
| FY27 Q2 | 53.8 |
Revenue increased, driven by the consolidation of 森六ReNova, higher production in North America, and increased sales and the effects of price revisions in the Chemicals business.
売上高・営業利益:森六ReNovaの連結効果、北米の増産、ケミカル事業の販売増・価格改定効果等により、増収増益Operating profit
| Period | ¥bn |
|---|---|
| FY25 Q1 | 1.4 |
| FY25 Q2 | 0.2 |
| FY25 Q3 | 0.3 |
| FY25 Q4 | 2.2 |
| FY26 Q1 | 1.1 |
| FY26 Q2 | 0.7 |
| FY26 Q3 | 0.2 |
| FY26 Q4 | 2.6 |
| FY27 Q1 | 2.3 |
| FY27 Q2 | 3.3 |
Profit increased, driven by the consolidation of 森六ReNova, higher production in North America, and increased sales and the effects of price revisions in the Chemicals business.
売上高・営業利益:森六ReNovaの連結効果、北米の増産、ケミカル事業の販売増・価格改定効果等により、増収増益Ordinary profit
| Period | ¥bn |
|---|---|
| FY25 Q1 | 1.6 |
| FY25 Q2 | -1.0 |
| FY25 Q3 | 0.2 |
| FY25 Q4 | 1.4 |
| FY26 Q1 | 0.9 |
| FY26 Q2 | 0.7 |
| FY26 Q3 | 0.3 |
| FY26 Q4 | 2.1 |
| FY27 Q1 | 2.3 |
| FY27 Q2 | 2.9 |
Net profit
| Period | ¥bn |
|---|---|
| FY25 Q1 | 1.5 |
| FY25 Q2 | -1.3 |
| FY25 Q3 | -0.1 |
| FY25 Q4 | -7.9 |
| FY26 Q1 | 0.5 |
| FY26 Q2 | 0.4 |
| FY26 Q3 | -0.1 |
| FY26 Q4 | 1.6 |
| FY27 Q1 | 3.5 |
| FY27 Q2 | 2.3 |
A ¥2.1 billion gain on bargain purchase arising from M&A was recorded as extraordinary income.
中間純利益: M&Aに伴い、負ののれん発生益21億円を特別利益として計上Dividend
Payout worked out from the FY27 forecast dividend and forecast EPS.
The company will steadily raise dividend levels, targeting a DOE of 3% or higher in the fiscal year ending March 2028.
Their own numbers
figures this company chose to report, a year ago against nowThe operating margin improved from 2.7% in the same period of the previous year to 5.5%.
Although PBR is trending upward, it remains below the target of 1.0x.
ROE for the fiscal year ending March 2027 is expected to rise temporarily due to the gain on bargain purchase arising from M&A.
The low–high ranges are Komori's estimate, not figures the company gave.
Everything else in the deck
By business
What moved
New initiatives
- The company will acquire 3 companies, including 森六ReNova, and integrate their technologies in decoration, electrical systems and weight reduction with technologies in exterior foaming and modularization.
- The company will establish NAMO Chemical, a joint venture with a South Korean company, to develop and manufacture auxiliary materials that prevent lithium-ion batteries from catching fire.
- The company will leverage 四国化工's high-value-added film technology to develop the medical and packaging materials fields in India and ASEAN.
- The company will transfer all of its interest in 广州森六 and pursue the optimization of its operations in China and the selective allocation and concentration of management resources.
Investment in equipment
planned for the year. The deck doesn't say how much is spent so far.
Buying back its own shares
The company will also respond flexibly to the acquisition and cancellation of treasury shares.
What decks usually leave out
COMPUTED = worked out by Komori from reported numbers; the rest are stated in this deckProgress toward the full-year forecast
¥5.6bn earned of the ¥8.0bn forecast. Against the old forecast (¥6.5bn) it would be 87%.
The rest of the year has to bring in ¥2.4bn, +38 pts off the usual pace.
| Period | % |
|---|---|
| FY24 | 18% |
| FY25 | 39% |
| FY26 | 39% |
| FY27 | 70% |
Margins and overheads
Financial targets
| Period | % |
|---|---|
| FY22 | 6.0 |
| FY23 | 1.9 |
| FY24 | 4.1 |
| FY25 | -11.1 |
| FY26 | 3.7 |
| FY27 | 7.4 |
| Period | % |
|---|---|
| FY22 | 51.6 |
| FY23 | 52.6 |
| FY24 | 53.4 |
| FY25 | 51.1 |
| FY26 | 53.5 |
| FY27 | 41.9 |
| Period | % |
|---|---|
| FY22 | 36.3 |
| FY23 | 115.8 |
| FY24 | 49.8 |
| FY26 | 67.3 |
| FY27 | 32.0 |
Yearly figures are computed by Komori from J-Quants results data (ROE = net profit ÷ average equity). The last point is this year's forecast or latest figure. Targets show only when this deck states them.
How they rate themselves against plan
Performance was generally in line with plan in regions outside China, but below plan in China.
中国以外の地域では、概ね計画どおりに推移